Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Bomback

Showing results (41-50 of 200) with videos related to

Pageof 20
Sort By:
Kidney International Reports|March 14, 2024
C3 Glomerulopathy: Novel Treatment ParadigmsBlanca Tarragon Estebanez, Andrew S Bomback
Blood Purification|January 25, 2012
Mineralocorticoid receptor blockade in chronic kidney diseaseAndrew S Bomback, Philip J Klemmer
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|February 6, 2008
Jack London's "chronic interstitial nephritis". A historical differential diagnosisAndrew S Bomback, Philip J Klemmer
AACE Clinical Case Reports|July 26, 2021
Acute Hyponatremia After a Religious FastRaphael J Rosen, Andrew S Bomback
Journal of the American Society of Nephrology : JASN|July 9, 2013
Can genetics risk-stratify patients with membranous nephropathy?Andrew S Bomback, Ali G Gharavi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 22, 2020
Belimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for TherapeuticsNestor Oliva-Damaso, Andrew S Bomback
American Journal of Nephrology|March 21, 2009
Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative reviewAndrew S Bomback, Philip J Klemmer
Kidney International|October 16, 2008
Renal injury in extreme obesity: the important role of aldosteroneAndrew S Bomback, Philip J Klemmer
Clinical Journal of the American Society of Nephrology : CJASN|March 18, 2016
Lupus Podocytopathy: A Distinct EntityAndrew S Bomback, Glen S Markowitz
American Journal of Nephrology|June 1, 2018
Membranous Nephropathy: Approaches to TreatmentAndrew S Bomback, Fernando C Fervenza
Pageof 20

Showing results (41-50 of 200) with videos related to

Sort By:
Pageof 20
Kidney International Reports|March 14, 2024
C3 Glomerulopathy: Novel Treatment ParadigmsBlanca Tarragon Estebanez, Andrew S Bomback
Blood Purification|January 25, 2012
Mineralocorticoid receptor blockade in chronic kidney diseaseAndrew S Bomback, Philip J Klemmer
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|February 6, 2008
Jack London's "chronic interstitial nephritis". A historical differential diagnosisAndrew S Bomback, Philip J Klemmer
AACE Clinical Case Reports|July 26, 2021
Acute Hyponatremia After a Religious FastRaphael J Rosen, Andrew S Bomback
Journal of the American Society of Nephrology : JASN|July 9, 2013
Can genetics risk-stratify patients with membranous nephropathy?Andrew S Bomback, Ali G Gharavi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 22, 2020
Belimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for TherapeuticsNestor Oliva-Damaso, Andrew S Bomback
American Journal of Nephrology|March 21, 2009
Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative reviewAndrew S Bomback, Philip J Klemmer
Kidney International|October 16, 2008
Renal injury in extreme obesity: the important role of aldosteroneAndrew S Bomback, Philip J Klemmer
Clinical Journal of the American Society of Nephrology : CJASN|March 18, 2016
Lupus Podocytopathy: A Distinct EntityAndrew S Bomback, Glen S Markowitz
American Journal of Nephrology|June 1, 2018
Membranous Nephropathy: Approaches to TreatmentAndrew S Bomback, Fernando C Fervenza
Pageof 20